Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking - PubMed (original) (raw)
. 2001 Jul 13;276(28):26509-15.
doi: 10.1074/jbc.M102769200. Epub 2001 May 14.
Affiliations
- PMID: 11352917
- DOI: 10.1074/jbc.M102769200
Free article
Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking
Xu Be et al. J Biol Chem. 2001.
Free article
Abstract
Docking between MEK1 and ERK2 is required for their stable interaction and efficient signal transmission. The MEK1 N terminus contains the ERK docking or D domain that consists of conserved hydrophobic and basic residues. We mutated the hydrophobic and basic residues individually and found that loss of either type reduced MEK1 phosphorylation of ERK2 in vitro and its ability to bind to ERK2 in vivo. Moreover, ERK2 was localized in both the cytoplasm and the nucleus when co-expressed with MEK1 that had mutations in either the hydrophobic or the basic residues. We then identified two conserved hydrophobic residues on ERK2 that play roles in docking with MEK1. Mutating these residues to alanine reduced the interaction of ERK2 with MEK1 in cells. These mutations also reduced the phosphorylation of MEK1 by ERK2 but had little effect on phosphorylation of MBP by ERK2. Finally, we generated docking site mutants in ERK2-MEK1 fusion proteins. Although the mutation of the MEK1 D domain significantly reduced ERK2-MEK1 activity, mutations of the putatively complementary acidic residues and hydrophobic residues on ERK2 did not change its activity. However, both types of mutations decreased the phosphorylation of Elk-1 caused by ERK2-MEK1 fusion proteins. These findings suggest complex interactions of MEK1 D domains with ERK2 that influence its activation and its effects on substrates.
Similar articles
- The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo.
Xu Be, Wilsbacher JL, Collisson T, Cobb MH. Xu Be, et al. J Biol Chem. 1999 Nov 26;274(48):34029-35. doi: 10.1074/jbc.274.48.34029. J Biol Chem. 1999. PMID: 10567369 - A bipartite mechanism for ERK2 recognition by its cognate regulators and substrates.
Zhang J, Zhou B, Zheng CF, Zhang ZY. Zhang J, et al. J Biol Chem. 2003 Aug 8;278(32):29901-12. doi: 10.1074/jbc.M303909200. Epub 2003 May 16. J Biol Chem. 2003. PMID: 12754209 - Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R Jr. Roskoski R Jr. Pharmacol Res. 2019 Apr;142:151-168. doi: 10.1016/j.phrs.2019.01.039. Epub 2019 Feb 20. Pharmacol Res. 2019. PMID: 30794926 Review. - Monomeric and dimeric models of ERK2 in conjunction with studies on cellular localization, nuclear translocation, and in vitro analysis.
Lee S, Bae YS. Lee S, et al. Mol Cells. 2012 Apr;33(4):325-34. doi: 10.1007/s10059-012-0023-4. Epub 2012 Mar 23. Mol Cells. 2012. PMID: 22450690 Free PMC article. Review.
Cited by
- Proteome-wide screening for mitogen-activated protein kinase docking motifs and interactors.
Shi G, Song C, Torres Robles J, Salichos L, Lou HJ, Lam TT, Gerstein M, Turk BE. Shi G, et al. Sci Signal. 2023 Jan 10;16(767):eabm5518. doi: 10.1126/scisignal.abm5518. Epub 2023 Jan 10. Sci Signal. 2023. PMID: 36626580 Free PMC article. - Eukaryotic initiation factor 6 regulates mechanical responses in endothelial cells.
Keen AN, Payne LA, Mehta V, Rice A, Simpson LJ, Pang KL, Del Rio Hernandez A, Reader JS, Tzima E. Keen AN, et al. J Cell Biol. 2022 Feb 7;221(2):e202005213. doi: 10.1083/jcb.202005213. Epub 2022 Jan 13. J Cell Biol. 2022. PMID: 35024764 Free PMC article. - Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals.
Keyes JD, Parsonage D, Yammani RD, Rogers LC, Kesty C, Furdui CM, Nelson KJ, Poole LB. Keyes JD, et al. Free Radic Biol Med. 2017 Nov;112:534-543. doi: 10.1016/j.freeradbiomed.2017.08.018. Epub 2017 Aug 24. Free Radic Biol Med. 2017. PMID: 28843779 Free PMC article. - The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells.
Wang Z, Guo Q, Wang R, Xu G, Li P, Sun Y, She X, Liu Q, Chen Q, Yu Z, Liu C, Xiong J, Li G, Wu M. Wang Z, et al. J Hematol Oncol. 2016 Nov 25;9(1):130. doi: 10.1186/s13045-016-0355-1. J Hematol Oncol. 2016. PMID: 27884160 Free PMC article. - Mapping the binding interface of ERK and transcriptional repressor Capicua using photocrosslinking.
Futran AS, Kyin S, Shvartsman SY, Link AJ. Futran AS, et al. Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8590-5. doi: 10.1073/pnas.1501373112. Epub 2015 Jun 29. Proc Natl Acad Sci U S A. 2015. PMID: 26124095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous